These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 11479211

  • 1. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.
    Liu G, Bode A, Ma WY, Sang S, Ho CT, Dong Z.
    Cancer Res; 2001 Aug 01; 61(15):5749-56. PubMed ID: 11479211
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch.).
    Wang SY, Feng R, Lu Y, Bowman L, Ding M.
    J Agric Food Chem; 2005 May 18; 53(10):4187-93. PubMed ID: 15884858
    [Abstract] [Full Text] [Related]

  • 3. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG, Huang C, Young MR, Li JJ, Dong Z, Pennie WD, Colburn NH.
    Oncogene; 1998 Dec 31; 17(26):3493-8. PubMed ID: 10030673
    [Abstract] [Full Text] [Related]

  • 4. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells.
    Liu G, Bibus DM, Bode AM, Ma WY, Holman RT, Dong Z.
    Proc Natl Acad Sci U S A; 2001 Jun 19; 98(13):7510-5. PubMed ID: 11416221
    [Abstract] [Full Text] [Related]

  • 5. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J, Ma C, Huang Y, Luo J, Huang C.
    Oncogene; 2003 Jan 16; 22(2):211-9. PubMed ID: 12527890
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.
    Dong Z, Ma W, Huang C, Yang CS.
    Cancer Res; 1997 Oct 01; 57(19):4414-9. PubMed ID: 9331105
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
    Li JJ, Dong Z, Dawson MI, Colburn NH.
    Cancer Res; 1996 Feb 01; 56(3):483-9. PubMed ID: 8564958
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol.
    Bode AM, Ma WY, Surh YJ, Dong Z.
    Cancer Res; 2001 Feb 01; 61(3):850-3. PubMed ID: 11221868
    [Abstract] [Full Text] [Related]

  • 9. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer.
    Dong Z, Huang C, Ma WY.
    Anticancer Res; 1999 Feb 01; 19(5A):3743-7. PubMed ID: 10625951
    [Abstract] [Full Text] [Related]

  • 10. 5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.
    Khanal P, Choi HK, Namgoong GM, Ahn SG, Yoon JH, Sohn H, Choi HS.
    Mol Carcinog; 2011 Dec 01; 50(12):961-71. PubMed ID: 21400615
    [Abstract] [Full Text] [Related]

  • 11. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP, Colburn NH, Verma AK.
    Oncogene; 1999 Oct 14; 18(42):5806-13. PubMed ID: 10523861
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS, Kim SH, Song YS, Surh YJ.
    Carcinogenesis; 2004 May 14; 25(5):713-22. PubMed ID: 14729583
    [Abstract] [Full Text] [Related]

  • 13. Organ-specific activation of activator protein-1 in transgenic mice by 12-o-tetradecanoylphorbol-13-acetate with different administration methods.
    Zhong S, Quealy JA, Bode AM, Nomura M, Kaji A, Ma WY, Dong Z.
    Cancer Res; 2001 May 15; 61(10):4084-91. PubMed ID: 11358830
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of epidermal growth factor-induced cell transformation by tannins.
    Nomura M, Tsukada H, Ichimatsu D, Ito H, Yoshida T, Miyamoto K.
    Phytochemistry; 2005 Sep 15; 66(17):2038-46. PubMed ID: 16153407
    [Abstract] [Full Text] [Related]

  • 15. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A, Hu J, Reeves R, Resar LM, Colburn NH.
    Oncogene; 2004 May 27; 23(25):4466-76. PubMed ID: 15064752
    [Abstract] [Full Text] [Related]

  • 16. Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
    Akihisa T, Matsumoto K, Tokuda H, Yasukawa K, Seino K, Nakamoto K, Kuninaga H, Suzuki T, Kimura Y.
    J Nat Prod; 2007 May 27; 70(5):754-7. PubMed ID: 17480098
    [Abstract] [Full Text] [Related]

  • 17. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K, Colburn NH.
    Oncogene; 2002 Mar 28; 21(14):2181-90. PubMed ID: 11948401
    [Abstract] [Full Text] [Related]

  • 18. Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway.
    Lin S, Li JJ, Fujii M, Hou DX.
    Int J Oncol; 2003 Apr 28; 22(4):829-33. PubMed ID: 12632075
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of tetrandrine on epidermal growth factor-induced cell transformation and its signal transduction.
    Nomura M, Yamazaki R, Takaya M, Kikuchi M, Takahashi-Nishioka T, Akiyama K, Akiyama N, Moritani S, Kobayashi S.
    Anticancer Res; 2007 Apr 28; 27(5A):3187-93. PubMed ID: 17970060
    [Abstract] [Full Text] [Related]

  • 20. Blackberry extracts inhibit activating protein 1 activation and cell transformation by perturbing the mitogenic signaling pathway.
    Feng R, Bowman LL, Lu Y, Leonard SS, Shi X, Jiang BH, Castranova V, Vallyathan V, Ding M.
    Nutr Cancer; 2004 Apr 28; 50(1):80-9. PubMed ID: 15572301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.